Citation: | CHU An-zhen, ZHANG Lan. The predictive value of systemic immune-inflammation index for intravenous immunoglobulin resistance in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2022, 20(11): 1884-1888. doi: 10.16766/j.cnki.issn.1674-4152.002727 |
[1] |
中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 等. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志, 2022, 60(1): 6-13.
The Subspecialty Group of Cardiolgy, The Society of Pediatrics, Chinese Medical Association; The Subspecialty Group of Rheumatology, The Society of Pediatrics, Chinese Medcial Association; The Subspecialty Group of Immunology, The Society of Pediatrics, Chinese Medical Association; et al. The expert consensus on diagnosis and acute-phase treatment of Kawasaki disease[J]. Chinese Journal of Pediatrics, 2022, 60(1): 6-13.
|
[2] |
SOSA T, BROWER L, DIVANOVIC A. Diagnosis and management of Kawasaki disease[J]. JAMA Pediatr, 2019, 173(3): 278-279. doi: 10.1001/jamapediatrics.2018.3307
|
[3] |
ARANE K, MENDELSOHN K, MIMOUNI M, et al. Japanese scoring systems to predict resistance to intravenous immunoglobulin in Kawasaki disease were unreliable for Caucasian Israeli children[J]. Acta Pediatr, 2018, 107(12): 2179-2184. doi: 10.1111/apa.14418
|
[4] |
陈玉萍, 张兰. 不同炎性指标检测在川崎病患儿诊断中的价值[J]. 中华全科医学, 2020, 18(3): 362-364. doi: 10.16766/j.cnki.issn.1674-4152.001247
CHEN Y P, ZHANG L. The value of different inflammatory indicators in children with Kawasaki disease[J]. Chinese Journal of General Practice, 2020, 18(3): 362-364. doi: 10.16766/j.cnki.issn.1674-4152.001247
|
[5] |
YI L P, ZHANG J, ZHONG J R, et al. Elevated levels of platelet activating factor and its acetylhydrolase indicate high risk of Kawasaki disease[J]. J Interferon Cytokine Res, 2020, 40(3): 159-167. doi: 10.1089/jir.2019.0141
|
[6] |
KANAI T, TAKESHITA S, KAWAMURA Y, et al. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: A multicenter study[J]. Heart Vessels, 2020, 35(10): 1463-1472. doi: 10.1007/s00380-020-01622-z
|
[7] |
JOMRICH G, PAIREDER M, KRISTO I, et al. High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma[J]. Ann Surg, 2021, 273(3): 532-541. doi: 10.1097/SLA.0000000000003370
|
[8] |
CARPIO-ORANTES L D, GAR ĆIA-MÉNDEZ S, HERNÁNDEZ-HERNÁNDEZ S N. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with COVID-19-associated pneumonia[J]. Gac Med Mex, 2020, 156(6): 527-531.
|
[9] |
陈芃螈, 杨超, 李刚, 等. 系统性免疫-炎症指数对川崎病患儿冠脉扩张的预测价值[J]. 中国免疫学杂志, 2020, 36(16): 2003-2006. doi: 10.3969/j.issn.1000-484X.2020.16.017
CHEN P Y, YANG C, LI G, et al. Predicting Value of systemic immune-inflammation index for coronary artery dilatation in patients with Kawasaki disease[J]. Chinese Journal of Immunology, 2020, 36(16): 2003-2006. doi: 10.3969/j.issn.1000-484X.2020.16.017
|
[10] |
MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American heart association[J]. Circulation, 2017, 135(17): e927-e999.
|
[11] |
YANG R N, CHANG Q, MENG X C, et al. Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis[J]. J Cancer, 2018, 9(18): 3295-3302. doi: 10.7150/jca.25691
|
[12] |
ISHII M, EBATO T, KATO H, et al. History and future of treatment for acute stage Kawasaki disease[J]. Korean Circ J, 2020, 50(2): 112-119. doi: 10.4070/kcj.2019.0290
|
[13] |
WU G, YUE P, MA F, et al. Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease[J]. Medicine, 2020, 99(6): e18535. DOI: 10.1097/MD.0000000000018535.
|
[14] |
ARORA K, GULERIA S, JINDAL A K, et al. Platelets in Kawasaki disease: Is this only a numbers game or something beyond?[J]. Genes Dis, 2019, 7(1): 62-66.
|
[15] |
JIN J, WANG J, LU Y D, et al. Platelet-derived microparticles: A new index of monitoring platelet activation and inflammation in Kawasaki disease[J]. Indian J Pediatr, 2019, 86(3): 250-255. doi: 10.1007/s12098-018-2765-2
|
[16] |
HAN S B, LEE S Y. Macrophage activation syndrome in children with Kawasaki disease: Diagnostic and therapeutic approaches[J]. World J Pediatr, 2020, 16(6): 566-574. doi: 10.1007/s12519-020-00360-6
|